International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 6 Issue 4 July-August 2024 Submit your research before last 3 days of August to publish your research paper in the issue of July-August.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 6 Issue 4
July-August 2024

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Coronary Stenosis in a Patient Under Pazopanib Therapy: A Case Study

Author(s) Nadir Wydad, Lkhoyaali Siham, Hachlaf Mariem, Abdi Chaimae, Lemsyeh Hajar, Boutayeb Saber, El ghissassi Ibrahim, M’rabti Hind, Errihani Hassan
Country Maroc
Abstract Tyrosine kinase inhibitors have transformed therapeutic approaches to cancer, marking a major advance in oncology. This article presents the clinical case of a 59-year-old moroccan patient with metastatic clear cell kidney cancer treated with pazopanib, who developed a cardiac vascular accident through coronary stenosis after 24 months of treatment with pazopanib. The main objective of this article is to illustrate the side effects of anti-angiogenic drugs and the crucial importance of monitoring these toxicities, particularly those of vascular origin, in order to prevent serious complications that could compromise the prognosis of a patient, regardless of the cancer disease itself. This case highlights the need for regular assessment of cardiovascular risk factors in patients receiving treatment with pazopanib, as well as increased vigilance for the appearance of signs or symptoms suggesting hematological or hepatic toxicities. Early and appropriate management of toxicities is essential to optimize the safety and effectiveness of renal cancer treatment with pazopanib, while preserving the patient's cardiovascular health.
Keywords Tyrosine kinase, Pazopanib, oncocardiology, kidney cancer
Field Médical / Pharmacie
Published In Volume 6, Issue 3, May-June 2024
Published On 2024-06-23
Cite This Coronary Stenosis in a Patient Under Pazopanib Therapy: A Case Study - Nadir Wydad, Lkhoyaali Siham, Hachlaf Mariem, Abdi Chaimae, Lemsyeh Hajar, Boutayeb Saber, El ghissassi Ibrahim, M’rabti Hind, Errihani Hassan - IJFMR Volume 6, Issue 3, May-June 2024. DOI 10.36948/ijfmr.2024.v06i03.22922
DOI https://doi.org/10.36948/ijfmr.2024.v06i03.22922
Short DOI https://doi.org/gt2447
View / Download PDF File

Share this


E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 6 Isu 4 Cover Page Vol 6 Isu 3 Cover Page Vol 6 Isu 2

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9898-5948-55 editor@ijfmr.com